33
/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
May 1, 2025
Public Timelines
Menu
Public Timelines
FAQ
Public Timelines
FAQ
For education
For educational institutions
For teachers
For students
Cabinet
For educational institutions
For teachers
For students
Open cabinet
Create
Close
Create a timeline
Public timelines
Library
FAQ
Edit
Download
Export
Duplicate
Premium
Embed
Share
112017
Category:
Other
Updated:
15 Nov 2017
new approvals in solid tumors
0
0
400
Contributors
Created by
Paweł Potocki
Attachments
Comments
Events
Imatynib
Gefitynib
Erlotynib
Sorafenib
Sunitynib Dasatynib
Lapatynib Nilotynib
Pazopanib
wemurafenib kryzotynib ruksolitynib
aflibercept aksytynib enzalutamid ewerolimus kabozantynib pertuzumab regorafenib
afatatynib dabrafenib denosumab ibrutynib trametynib trastuzumab-emtanzyna rad-223
alektynib lenwatynib kobimetynib osimertynib palbocyklib sonidegib
ceritinib niwolumab olaparyb pembrolizumab ramucyrumab
atezolizumab rukaparyb olaratumab
abemacyklib awelumab brygantynib niraparyb neratynib rybocyklib
About & Feedback
Terms
Privacy
Library
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Comments